June 18, 2021
Quadruple witching is usually accompanied by price volatility, as well as increased trading volume
Pre-open indications: 3 BUY – AGTC, RARE, VYGR; 4 SELLs into Strength - profit: CRSP, EDIT, FATE, NTLA; 1 Maintain SELL: BSTG
My version of the morning’s “indications” is about what you need to know; it’s what could happen or materialize after the opening and what might happen during the session
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!
June 16, 2021
A scorecard of earnings releases of 35 covered companies
The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status"
32 to date <MESO is added>
June 20, 2021
Witching Friday’s come and gladly go
Pre-open indications: 6 HITs and 2 MISS
My comments try to distinguish the temporary from real pricing digression or progress.
If you’re looking for sector intel, ideas and facts or numbers (which don’t lie) in a volatile climate, RMi defines the rigors of share pricing! My comments distinguish the temporary from real pricing digression or progress.
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors!
June 16, 2021
A scorecard of earnings releases of 35 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status" 32 to date <MESO is added>
June 16, 2021
A scorecard of of 35 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" is a reflection of this universe's investing "status"
May 28, 2021
Wouldn’t quit, walked-away or resigned fit the action specifically Maintaining Sell WHY and WHAT is behind the latest SEC 8-K filing where RSM US LLP (the accounting/audit firm) stated “that the client-auditor relationship between the Company and RSM has ceased. Prior to such notification, RSM had recently served as the Company’s independent auditors through the recent Form 10-Q filing by the Company on May 24, 2021. The change in accountants was NOT recommended by the audit committee of the board of directors.” <read more>
7 hours 12 min ago
RegMed Investors’ (RMi) closing bell: could have been worse
June 20, 2021
RegMed Investors’ (RMi) closing bell: could have been worse
June 18, 2021
RegMed Investors’ (RMi) pre-open: the witch is on the stick
June 17, 2021
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector rallied after a two (2) session flogging
June 17, 2021
RegMed Investors’ (RMi) pre-open: uncertainty as liquidity of pricing reflects conflicted value
June 16, 2021
RegMed Investors’ (RMi) closing bell: as expected, gravity induced by the Fed was a sector force
June 16, 2021
RegMed/Cell and Gene Therapy Earnings Scorecard Q1/21 LPS Results
June 16, 2021
Q2/21 Earnings - (LPS - loss-per-share) Results
June 16, 2021
RegMed Investors’ (RMi) pre-open: Waiting for Powell
© 2021 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
